Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IN
Inspire Medical Systems, Inc.
INSP
Mkt Cap
$1.99B
Volume
296.21K
Next Earnings
November 2nd
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IN
INSP
IN
Inspire Medical Systems, Inc.
INSP
News
·
Global Bioelectronic Medicine Market Anticipates Impressive Growth Trajectory of ~10% by 2034 | DelveInsight
Mkt Cap
$1.99B
Volume
296.21K
Next Earnings
November 2nd
Chart
Financials
Earnings
News
About
Insider
Filings
Global Bioelectronic Medicine Market Anticipates Impressive Growth Trajectory of ~10% by 2034 | DelveInsight
The global bioelectronic medicine market is projected to grow from USD 8.9 billion in 2025 to USD 21.6 billion by 2034, driven by increasing adoption of neuromodulation technologies, advances in implantable devices, AI integration, and expanding applications beyond neurological disorders. North America leads the market with 44% share, while Asia-Pacific is expected to record the fastest growth rate.
GlobeNewswire Inc. · Oct 6, 2026
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Inspire Medical Systems is building momentum around its fifth-generation Inspire V system with expanding clinical evidence and improving reimbursement clarity across all six WISeR states. However, Q2 revenues declined 7.6% to $200.6M due to persistent coding disruption, and GLP-1 therapy adoption poses a risk to near-term procedure volumes. The company faces execution risks in translating patient-flow initiatives into sustained growth.
Zacks Investment Research · Sep 23, 2026
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
West Pharmaceutical Services (WST) is well-positioned for growth driven by strong demand for high-value products (HVPs), expanding biologics exposure, and regulatory-driven Annex 1 conversions. The company expects about 200 basis points of revenue growth from Annex 1 upgrades in 2026. However, weak West Vantage segment performance due to a cyber incident and commodity inflation remain near-term concerns. The stock has gained 33.1% year-to-date.
Zacks Investment Research · Sep 18, 2026
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
The Medical Information Systems industry is positioned for growth driven by AI integration in healthcare, with a projected 39.7% CAGR through 2031. However, rising cybersecurity threats pose significant risks. Three stocks—Inspire Medical Systems, American Well, and Butterfly Network—are well-positioned to benefit from demand for AI-powered solutions and digital health platforms, though the industry has underperformed the broader market over the past year.
Zacks Investment Research · Sep 11, 2026
Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
Inspire Medical Systems (INSP) reported Q2 2026 earnings that beat estimates with adjusted EPS of 14 cents versus expected loss of 22 cents, and raised full-year 2026 guidance. However, U.S. revenues declined 9.6% year-over-year due to coding and reimbursement challenges, partially offset by strong 33.6% international revenue growth. The stock has declined 4.1% since earnings despite the Zacks Rank #1 (Strong Buy) rating.
Zacks Investment Research · Sep 2, 2026
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors
Casey M. Tansey, a long-serving board member of Inspire Medical Systems who led the company's Series A financing in 2007 as a representative of U.S. Venture Partners, is retiring from the board effective July 30, 2026. CEO Tim Herbert praised Tansey's contributions and mentorship throughout the company's founding, IPO, and growth phases. Inspire plans to announce a replacement director soon.
GlobeNewswire Inc. · Jul 22, 2026
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
Inspire Medical Systems presented new clinical data at SLEEP 2026 demonstrating the effectiveness of its Inspire V hypoglossal nerve stimulation system for obstructive sleep apnea treatment. Key findings include significant reductions in hypoxic burden, improved cardiovascular outcomes compared to CPAP therapy, and higher patient adherence rates. The company also published studies identifying predictors for therapy eligibility and presented results from its 5,000-patient ADHERE registry showing 62% median AHI reduction.
GlobeNewswire Inc. · Jun 16, 2026
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
Inspire Medical Systems announced that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on June 26, 2026 at 10:00 a.m. Eastern Time. The company, which develops minimally invasive solutions for obstructive sleep apnea treatment, will present via live webcast with a replay available for two weeks.
GlobeNewswire Inc. · Jun 12, 2026
Stock Market Today: Dow, S&P 500, Nasdaq Futures Rise As Traders Monitor US-Iran Ceasefire— Duolingo, Pinterest, AMD In Focus (UPDATED)
U.S. stock futures rose on Tuesday following President Trump's announcement of 'Project Freedom' to reopen commercial shipping through the Strait of Hormuz, amid US-Iran tensions. Key movers included Duolingo (down 12.77% despite beating estimates due to weak guidance), Pinterest (up 16.59% on strong Q1 results), AMD (up 1.94% ahead of earnings), and Inspire Medical Systems (down 21.04% after narrowing revenue guidance). Analysts remain optimistic on tech stocks driven by AI investments and strong corporate earnings.
Benzinga · May 5, 2026
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
Inspire Medical Systems announced it will release Q1 2026 financial results on May 4, 2026, followed by a management conference call at 5:00 p.m. ET. The company will discuss financial performance and recent business developments. A webcast will be available for investors, with a replay archived for two weeks.
GlobeNewswire Inc. · Apr 6, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
IN
INSP
Inspire Medical Systems, Inc.
Buy
Sell
Market
Limit
Soon
INSP
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any INSP yet.
Related Tickers
Earnings